Top

Primary and Secondary Packaging of Prescription Medications

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

This scope was carved out of 36E79725R0071.

The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedFeb 4

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Bottling, labeling, and barcoding of prescription drugs in compliance with HDA, DSCSA, and VA BCMA standards.

Similar Contracts

Same NAICS industry code

NAICS: 325413

New

Federal

NOI to Sole Source to 10X Genomics

Solicitation # NOI-OD-26-009308

The National Institutes of Health intends to award a one-year, firm-fixed-price sole source contract to 10X Genomics for the acquisition of reagents and consumables, specifically the GEM-X Universal 5 prime Gene Expression v3 Kit. These materials are essential for the Early Detection of Lung Diseases project at the NIH Clinical Center in Bethesda, Maryland, as they are exclusively compatible with the proprietary 10X Genomics Chromium platform. The reagents enable high-resolution gene expression profiling and immune repertoire analysis necessary for identifying early biomarkers and understanding molecular mechanisms of lung diseases. Because the required reagents are proprietary and cannot be substituted without compromising research integrity and experimental continuity, the government is utilizing Simplified Acquisition Procedures under FAR Part 13. This notice serves as an intent to award rather than a request for quotations. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and Product Service Code 6640 for Laboratory Equipment and Supplies.

National Institutes Of Health Olao

POSTED

DEADLINE

BCL27*375818-Biomeriuex-Reagents

Solicitation # SRC0000036247

Clinical Laboratory Services

POSTED

DEADLINE

Cutaneous Leishmaniasis Detection Test Kit SupplierThis subcontract involves the supply of FDA-cleared, hand-held, qualitative, in vitro immunohormatographic assay kits to prime contractors supporting DLA Troop Support medical supply contracts. Specifically, the provider will supply the CLD Detect Rapid Test for Cutaneous Leishmaniasis, identified by NSN 6550016339195, designed for the detection of Leishmania species antigen. Each delivery consists of two complete test kits featuring an 18-month shelf life. The contract requires strict adherence to MIL-STD-2073-1E for packaging and Medical Marking Standard No. 1 for item marking. Managed under NAICS code 325413, the agreement is associated with the Department of Defense and the Medical Supply Chain MD Surg FSF, with the place of performance located at APO 09227-0000.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Legionella Urine Antigen Test KitsThis subcontract involves the manufacture, packaging, and delivery of specialized Legionella pneumophila urine antigen test kits for prime contractors serving Public Health Ontario. The supplier is responsible for utilizing specific diagnostic reagents and antigen-capture antibodies to produce validated medical diagnostic kits. To be eligible, the provider must hold medical device regulatory certification from Health Canada, the FDA, or an equivalent recognized diagnostic standard. The contract is managed under the Government of Ontario through the OAHPP, with a focus on the physical shipment of these kits to designated facilities. Interested parties must respond by October 5, 2026, in accordance with NAICS code 325413.

OAHPP (Public Health Ontario)

POSTED

DEADLINE

163627001 ACAN - Legionella Urine Antigen Test Kits

Solicitation # rfi_2019

Public Health Ontario is issuing an Advance Contract Award Notice under project reference 163627001 to signal its intent to enter into a non-competitive, sole source contract with Abbott Rapid Diagnostics ULC. The contract is for the supply and delivery of Legionella Urine Antigen Test Kits designed for the qualitative detection of Legionella pneumophila serogroup 1 antigen in urine specimens from patients with pneumonia symptoms. While the agency intends to proceed with a sole source award, this notice provides other suppliers an opportunity to demonstrate their ability to satisfy the requirements. Interested suppliers must submit a Statement of Capabilities via the Ontario Tenders Portal by the deadline of October 5, 2026. The submission must include specific project details, contractor information, and a description of capabilities as outlined in the notice. This process is categorized as a solicitation under NAICS code 325413, and the primary point of contact for the procurement is Arlene Saw. This request is not a call for tenders but a formal notification of the intended award strategy.

OAHPP (Public Health Ontario)

POSTED

DEADLINE

Notice of Intent to Award- Blanket Purchase Agreement (BPA) for LIBRE Continuous Glucose Monitors BPA on an As Needed Basis

Solicitation # IHS1521817_BPA_for_LIBRE_Continuous_Glucose_Monitors

The Navajo Area Indian Health Service, Chinle Service Unit, intends to establish a Blanket Purchase Agreement with National Environmental, INC (DBA Buy Indian Medical) for the procurement of Freestyle LIBRE Glucose Monitors on an as-needed basis. This award is designated for an Indian Small Business Economic Enterprise under NAICS code 325415, with an anticipated period of performance lasting one year. The supplies will support the population health department at the Chinle Comprehensive Health Care Facility in Arizona. While the government currently intends to award this specific BPA, other capable sources may submit capability statements, price lists, and catalogs to the primary point of contact by September 30, 2026, at 1:00pm MST. Additional BPAs may be established if deemed in the best interest of the government. This notice serves as an intent to award and is not a formal request for quotations, meaning no solicitation will be issued.

Navajo Area Indian Health Svc

POSTED

DEADLINE

Supply of Benzonatate Capsules (100mg)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Ciprofloxacin Diagnostic Sensitivity DiscsThis subcontract involves the supply of Ciprofloxacin diagnostic sensitivity discs for prime contractors supporting DLA Troop Support medical supply contracts. The provider is responsible for manufacturing or sourcing discs with a potency of 5 micrograms per disk, packaged in vials of 50, with a total delivery requirement of 1,000 vials. A critical component of the agreement is the management of cold-chain logistics to ensure storage and transport temperatures remain between -20 and 8 degrees Celsius. The contract is issued by the Department of Defense under the Medical Supply Chain MD Surg FSF agency and requires strict compliance with the Buy American Act and DFARS 252.225-7001. Performance is designated for FPO 09566-4008 under NAICS code 325413. The solicitation was posted on September 16, 2026, with a response deadline of September 22, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Cyanide-Free Lysing ReagentThis subcontract involves the supply of cyanide-free erythrocyte lytic agent for prime contractors supporting DLA Troop Support Medical Supply Chain projects. The reagent is used for the quantitative determination of hemoglobin and the counting, sizing, and optical measurement of leukocytes under NSN 6550016889389. The provider must ensure the reagent is stored and transported within a temperature-controlled range of 4 to 25 degrees Celsius and delivered to designated DLA locations. Eligible candidates must maintain an active SAM registration. This opportunity is managed by the Department of Defense under NAICS code 325413, with a response deadline of September 22, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-26-T-445L

Solicitation SPE2DS-26-T-445L is a fixed-price request for quotations issued by DLA Troop Support Medical Supply Chain for one box of blood chemistry control sets, specifically i-STAT HS-TNI Calibration Verification Levels 1-3 (NSN 6550-01-736-1643). Each box must contain six vials, with each vial containing 1 mL of frozen human plasma. The materials are used to verify the calibration of the i-STAT High Sensitivity Troponin-I test across its reportable range and must be stored frozen at or below negative 20 degrees Celsius. The contract mandates strict quality and delivery standards, including a non-extendable shelf life of three months, with no more than 14 days elapsed from the date of manufacture to the date of government delivery. Packaging must be commercial and sealed to protect contents from damage, with palletization following RP001 and marking adhering to Medical Marking Standard No. 1. Delivery is set for USNS Comfort (FPO AE 09566-4008) with a lead time of 20 days after receipt of order. Invoicing must be processed through the Wide Area WorkFlow system, and the award is subject to various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and specific cybersecurity requirements for safeguarding covered defense information.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-445G

Solicitation SPE2DS-26-T-445G is a request for quotes issued by the DLA Troop Support Medical Supply Chain for the acquisition of one unit of cyanide-free lysing reagent, identified by NSN 6550-01-688-9389. This erythrocyte lytic agent is used on DXH 500 series systems for the quantitative determination of hemoglobin and the counting, sizing, and optical measurement of leukocytes. The reagent must be stored between 4 and 25 degrees Celsius and has a non-extendable shelf life of 12 months, with a requirement that no more than one month elapses from the date of manufacture to the date of delivery to the government. The contract specifies that delivery is required within 20 days after order, with FOB, inspection, and acceptance all occurring at the destination. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers. Marking must comply with Medical Marking Standard No. 1 and MMS1C, including the date of manufacture, expiration or retest date, and the contract or lot number. All quotes must be submitted via the DLA Internet Bid Board System (DIBBS) by September 22, 2026. The procurement incorporates various FAR and DFARS clauses, including requirements for the Buy American Act, basic safeguarding of covered contractor information systems, and the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-447H

Solicitation SPE2DS-26-T-447H, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter home use. Each case contains 12 kits with two tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months. A critical delivery requirement stipulates that no more than one month may elapse from the date of manufacture to the date of delivery to the government. Delivery is required within 20 days after receipt of order, with the destination point specified as the USS Washington (SSN 787) at FPO AE 09583. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires all labels to include the contract number, lot number, and dates of manufacture and expiration. Packaging must be commercial and compliant with DLA requirement RP001, utilizing sealed unit containers to prevent damage. The procurement incorporates various federal regulations, including the Buy American Act, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information. Invoicing and payment must be processed electronically through the Wide Area Workflow system. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

3 days ago

DEADLINE

in 3 days

View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 424210

New

Federal

Pharmaceutical Distribution ServicesThis subcontract for Pharmaceutical Distribution Services involves the supply and distribution of Glipizide Tablets to prime contractors supporting various government entities, including the VA, DoD, BOP, IHS, and FHCC. The scope of work encompasses comprehensive warehousing, inventory management, and FOB Destination shipping specifically tailored for Consolidated Mail Order Pharmacies and State Veterans Homes. To ensure product integrity, the operations utilize climate-controlled warehousing and specialized pharmaceutical transport vehicles for delivery to designated government destinations. Managed by Nac Pharmaceuticals under the Department of Veterans Affairs, the contract falls under NAICS code 424210, with a response deadline set for October 8, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the packaging and labeling of Glipizide Tablets to support prime contractors delivering pharmaceutical supplies to the VA, DoD, BOP, IHS, and FHCC. The scope of work includes bottling, blister packing, and the application of labels that meet specific VA and DoD requirements using specialized pharmaceutical machinery. All operations must strictly adhere to FDA cGMP standards and the requirements outlined in Section 5 of the contract scope to ensure the tablets are ready for final shipment. This opportunity is issued by Nac Pharmaceuticals under the Department of Veterans Affairs, with a response deadline of October 8, 2026.

All Other Miscellaneous Manufacturing

POSTED

DEADLINE

Glipizide Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Glipizide Tablets to support pharmaceutical supply contracts for the Department of Veterans Affairs, DoD, BOP, IHS, and FHCC. The scope of work encompasses the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, tablet formulation, compression, and rigorous quality control testing. The selected provider must utilize pharmaceutical grade manufacturing equipment and maintain strict compliance with FDA cGMP standards. Key deliverables include the finished Glipizide Tablets and the provision of an 11-digit National Drug Code number. This subcontract opportunity falls under NAICS code 325412, with a response deadline of October 8, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--Glipizide Tablets

Solicitation # 36E79726R0031_1

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

6505--2027-2028 Influenza Virus Vaccine

Solicitation # 36E79726R0035

Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Distribution and FulfillmentThis subcontract for Pharmaceutical Distribution and Fulfillment, managed by Nac Pharmaceuticals for the Department of Veterans Affairs, focuses on the storage and shipment of Lisinopril tablets. The provider is responsible for the warehousing of finished products using climate-controlled facilities and logistics management software to support the Department of Veterans Affairs and DoD Pharmaceutical Prime Vendor Program projects. The scope of work includes coordinating FOB Destination shipments to federal health centers, CMOPs, and TMOPs, ensuring the product is delivered to all designated distribution points. This opportunity falls under NAICS code 423450, with a response deadline set for September 24, 2026.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThis subcontract for Pharmaceutical Packaging and Labeling Services involves the filling, labeling, and primary packaging of Lisinopril tablets to support Department of Veterans Affairs pharmaceutical supply projects. The selected provider will be responsible for filling intermediate containers and applying compliant labels, including 11-digit NDC numbers, within a sterile or controlled packaging environment to ensure the tablets are ready for distribution. To qualify for this engagement with Nac Pharmaceuticals, the contractor must possess a valid FEI number and maintain strict FDA cGMP compliance for packaging. The opportunity was posted on September 3, 2026, with a response deadline of September 24, 2026, falling under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Lisinopril Tablet ManufacturingNac Pharmaceuticals is seeking a subcontractor for the manufacturing of Lisinopril tablets to support Department of Veterans Affairs pharmaceutical supply projects. The selected provider will be responsible for the entire production process, including the chemical synthesis of the active pharmaceutical ingredient, formulation, compression into tablets, and rigorous quality control testing in accordance with ACS and USP-NF specifications. To qualify, the manufacturer must operate FDA-compliant cGMP facilities and possess a valid FEI number to ensure the delivery of bulk finished tablets that meet all purity and potency standards. This subcontract opportunity was posted on September 3, 2026, with a response deadline of September 24, 2026, falling under NAICS code 325412.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

36E79726R0032 Lisinopril Tablets (VA-27-00004937)

Solicitation # 36E79726R0032

The Department of Veterans Affairs, through the National Acquisition Center, is soliciting proposals for an unrestricted contract to provide an uninterrupted source of supply for Lisinopril Tablets. This procurement supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed via the VA and DOD Pharmaceutical Prime Vendor Programs. The contract consists of a one-year base period with four pre-priced one-year option periods. Award will be made to a single responsible offeror based on an aggregate evaluation of all 22 line items across the base and option years. The scope of work includes the delivery of Lisinopril in strengths of 2.5mg, 5mg, 10mg, 20mg, 30mg, and 40mg across various package sizes. Strict packaging and labeling requirements are mandated, including the use of a unique NDC number, specific cylindrical bottle dimensions with a minimum 120cc volume and 5.75 inch circumference, and safety-caps that are either convertible or deshellable. Labels must be compatible with VA labels and fit specific dimensions of 5.25 by 2 inches. Offers are due by September 24, 2026, at 2:30 PM CST, and must include pricing for all line items and a 0.5 percent cost recovery fee.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Pharmaceutical Logistics and Distribution to Prime Vendors

General Warehousing and Storage

POSTED

DEADLINE

Supply of Metoprolol Tartrate Active Pharmaceutical Ingredient (API)

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

NDC Registration and FDA Compliance Services

Administrative Management and General Management Consulting Services

POSTED

8 months ago

DEADLINE

N/A

View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS